HHS Logo U.S. Department of Health & Human Services Divider arrowNIH logo National Institutes of Health Alt desc
Skip Over Navigation Links
Chip

Meet Chip

Explore this interactive model of the innovative developments from the NCATS-supported Tissue Chip for Drug Screening program.


Work with Us

The tissue chip program is designed to improve the way new drugs are developed and tested. Learn more about how you can join this effort.

Contact Danilo Tagle, Ph.D.

Tissue Chip for Drug Screening

The Tissue Chip for Drug Screening program aims to develop bioengineered devices to improve the process of predicting whether drugs will be safe or toxic in humans. Learn more.

Find NCATS Programs & InitiativesAccess NCATS Expertise & Resources

About Tissue Chip

Read more about the Tissue Chip program and its goal to create 3-D organs-on-chips.

Funding Information

Find more information about how the Tissue Chip program funds innovative research.

Why Tissue Chip Matters

More than 30 percent of promising medications have failed in human clinical trials because they are determined to be toxic — despite promising pre-clinical studies in animal and cell models. Tissue chips are a newer, human cell–based approach to this challenge. The chip devices may enable scientists to predict more accurately how effective a therapeutic candidate would be in clinical studies.

Eliminating toxic and/or ineffective drugs earlier in the development process would save time and money. These human tissue chips also could teach us a great deal about disease progression, enabling researchers to better prevent, diagnose and treat disorders. Learn more about the Tissue Chip program.

This content requires the free Adobe Flash Player. Get Flash.

You can watch the video with JavaScript turned on. To view it without JavaScript and Flash, you can access the text-only version of the video.

Watch the Tissue Chip for Drug Screening video to learn more about the program.